Patient preferences and adherence to adjuvant GnRH analogs among premenopausal women with hormone receptor positive breast cancer
Jasmine Sukumar(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Sagar Sardesai(The Ohio State University Wexner Medical Center), Margaret E. Gatti‐Mays(National Cancer Institute), Michael Grimm, Robert Wesolowski(The Ohio State University Wexner Medical Center), Leslie Appiah(University of Colorado Anschutz Medical Campus), Namrata Vilas Shinde(The Ohio State University Wexner Medical Center), Daniel G. Stover(Harvard University), Dionisia Quiroga(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Bhuvaneswari Ramaswamy(The Ohio State University), Mathew Cherian(The Ohio State University Wexner Medical Center), Marilly Palettas(The Ohio State University Wexner Medical Center), Maryam B. Lustberg(Yale Cancer Center), Mahmoud Kassem(The Ohio State University), Nicole Williams(The Ohio State University), Julie Stephens(The Ohio State University), Ashley Pariser(The Ohio State University Wexner Medical Center), Jeffrey Van Deusen(The Ohio State University Wexner Medical Center)
Cited by 18
Related Papers
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
|Journal of Clinical Oncology|2014|1.2k
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update
|Journal of Clinical Oncology|2020|1.1k
Response and resistance to BET bromodomain inhibitors in triple-negative breast cancer
|Nature|2016|629
Current Landscape of Immunotherapy in Breast Cancer
|JAMA Oncology|2019|409
Integrin-β4 identifies cancer stem cell-enriched populations of partially mesenchymal carcinoma cells
|Proceedings of the National Academy of Sciences|2017|373